B. Oliosi

发表

Slow dissociation of partial agonists from the D₂ receptor is linked to reduced prolactin release.

L. Carboni, S. Bertani, P. Cavanni, 2012, The international journal of neuropsychopharmacology.

Stable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonists

A. Capelli, C. Gotti, M. Mugnaini, 2011, British journal of pharmacology.

Synthesis and structure-activity relationship of new 1,5-dialkyl-1,5-benzodiazepines as cholecystokinin-2 receptor antagonists.

G. Tedesco, A. Reggiani, R. Barnaby, 2011, Bioorganic & medicinal chemistry.

1,2,4-Triazolyl octahydropyrrolo[2,3-b]pyrroles: A new series of potent and selective dopamine D3 receptor antagonists.

C. Heidbreder, L. Castelletti, P. Cavallini, 2016, Bioorganic & medicinal chemistry.

Integration of lead optimization with crystallography for a membrane-bound ion channel target: discovery of a new class of AMPA receptor positive allosteric modulators.

P. Woollard, K. Thewlis, S. Ward, 2011, Journal of medicinal chemistry.

N-substituted pyrrolidines and tetrahydrofurans as novel AMPAR positive modulators.

K. Thewlis, S. Ward, C. Mookherjee, 2010, Bioorganic & medicinal chemistry letters.

Discovery of N-[(2S)-5-(6-fluoro-3-pyridinyl)-2,3-dihydro-1H-inden-2-yl]-2-propanesulfonamide, a novel clinical AMPA receptor positive modulator.

Paul W Smith, K. Thewlis, S. Ward, 2010, Journal of medicinal chemistry.

Synthesis and receptor-binding affinity of dipeptoid cholecystokinin ligands

G. Tarzia, D. Donati, G. Araldi, 1996 .

Pharmacological characterization of N‐[(2S)‐5‐(6‐fluoro‐3‐pyridinyl)‐2, 3‐dihydro‐1H‐inden‐2‐yl]‐2‐propanesulfonamide: a novel, clinical AMPA receptor positive allosteric modulator

S. Ward, L. Lacroix, L. Dawson, 2017, British journal of pharmacology.

Synthesis and evaluation of novel 1,5-Benzodiazepines as potent and selective CCK-B ligands. Effect of the substitution of the N-5 phenyl with alkyl groups

D. Donati, B. Oliosi, A. Ursini, 1996 .

1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.

K. Read, G. Tedesco, D. Minick, 2010, Journal of medicinal chemistry.

6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.

K. Read, G. Tedesco, R. Carletti, 2010, Journal of medicinal chemistry.

Occupancy of Brain Dopamine D3 Receptors and Drug Craving: A Translational Approach

E. Rabiner, E. Pich, J. Beaver, 2013, Neuropsychopharmacology.

Identification of novel alpha7 nAChR positive allosteric modulators with the use of pharmacophore in silico screening methods.

J. Kew, A. Capelli, S. Teague, 2010, Bioorganic & medicinal chemistry letters.

Oxa‐azaspiro Derivatives: a Novel Class of Triple Re‐uptake Inhibitors

G. Tedesco, F. Micheli, P. Cavanni, 2010, ChemMedChem.